Physician profile
Jonathan Dunn
NPI 1285999755
$1,855.51
in general payments reported to CMS, 2019-2025
16 companies · $15.57 in 2025
The $15.57 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.47 · 2020: $29.86 · 2021: $86.04 · 2022: $43.53 · 2023: $974 · 2024: $680 · 2025: $15.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,669.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $457.54 | 2022-2025 | Octrode, Proclaim, Penta |
| Protega Pharmaceutials INC | $338.99 | 2024 | Roxybond |
| Collegium Pharmaceutical, INC. | $249.57 | 2023 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $164.17 | 2023-2024 | Relistor |
| Edwards Lifesciences Corporation | $115.90 | 2020-2021 | |
| Lilly USA, LLC | $101.37 | 2023 | Emgality, Reyvow |
| Scilex Pharmaceuticals INC. | $66.34 | 2023 | Ztlido |
| Pfizer INC. | $65.60 | 2023 | |
| Azurity Pharmaceuticals, INC. | $65.49 | 2023 | Horizant |
| Kowa Pharmaceuticals America, INC. | $55.97 | 2023 | Seglentis |
| Idorsia Pharmaceuticals US INC | $48.14 | 2023 | Quviviq |
| Almatica Pharma LLC | $42.38 | 2023 | Gralise |
| Covidien Lp | $26.47 | 2019 | |
| Boston Scientific Corporation | $21.41 | 2022 | |
| Bioventus LLC | $21.26 | 2023 | Stimrouter Implantable Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $14.91 | 2023 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.